Khondrion
Phase 3Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Founded
2013
Focus
Small Molecules
About
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Funding History
4Total raised: $35.3M
Grant$2.8MEurostarsJun 15, 2021
Series B$20MBioGeneration VenturesJun 15, 2020
Series A$10MBioGeneration VenturesJun 15, 2017
Seed$2.5MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2013
LocationNijmegen, Netherlands
StagePhase 3
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile